SPC
OGN icon

Slate Path Capital’s Organon & Co OGN Stock Holding History

Slate Path Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,463,963
Closed -$47.1M – 65
2024
Q3 		$47.1M Sell
2,463,963
-2,929,823
-54% -$60.7M 0.73% 39
2024
Q2 		$112M Buy
5,393,786
+248,000
+5% +$4.93M 2.13% 18
2024
Q1 		$96.7M Buy
5,145,786
+1,565,000
+44% +$26.9M 1.92% 22
2023
Q4 		$51.6M Buy
+3,580,786
New +$48.7M 1.15% 30
2021
Q3 		– Sell
-420,000
Closed -$12.7M – 41
2021
Q2 		$12.7M Buy
+420,000
New +$13.8M 0.71% 25

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Slate Path Capital's OGN Position: Q4 2024 in Review

Slate Path Capital sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 2,463,963 shares — an estimated $47.1M sold.

Slate Path Capital first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $112M in Q2 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Slate Path Capital reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Slate Path Capital sold 2,463,963 Organon & Co shares in Q4 2024, an estimated $47.1M.
  • Slate Path Capital first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Slate Path Capital's Organon & Co position peaked at $112M in Q2 2024.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Slate Path Capital's 13F filing for Q4 2024, filed 14 Feb 2025.